Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, today announced that it is making available its white paper, From Biologics to Biosimilars - How Will the Market Evolve? Addressing timing, hurdles that must be overcome and ultimately who has the most to lose, this paper guides readers through the biologics/biosimilars conundrum with the aid of data and analysis from Pharmaview.

  Topics covered in the white paper include:    -- Patent expiries and anticipated biosimilar entry dates for key biologic      brands   -- Companies at risk from biosimilars   -- Who the key competitors will be in the biosimilars market   

If you would like to download a copy of the white paper, please visit: http://www.decisionresources.com/form/downloads/Pharmaview-WhitePaper.pdf

About Pharmaview

Pharmaview provides continually updated analysis on over 1,500 marketed and pipeline products from over 120 companies, covering 136 product classes and 14 therapy areas - complete with seven-year product-level forecasts for over 1,000 products.

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

   For more information, contact:     Heather Hilty                    Elizabeth Marshall    Decision Resources               Decision Resources, Inc.    781-296-2536                     781-296-2563    hhilty@dresources.com            emarshall@dresources.com 

First Call Analyst:
FCMN Contact:

SOURCE: Decision Resources

CONTACT: Heather Hilty of Decision Resources, +1-781-296-2536,
hhilty@dresources.com; or Elizabeth Marshall of Decision Resources, Inc.,
+1-781-296-2563, emarshall@dresources.com

Activity Against MRSA is the Most Important Attribute Influencing Physicians' Antibiotic Selection for the Treatment of Skin and Skin Structure Infections

View Now